REDWOOD CITY, Calif. & NEW ORLEANS--(BUSINESS WIRE)--Karius, Inc., a life sciences company focused on conquering infectious diseases, today announced new data from four studies presented at the ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A pivotal multi-center study published in Clinical Infectious Diseases demonstrates the effectiveness of the Karius Test®, a blood test based on metagenomics ...

Karius, a startup developing liquid biopsy tests for infectious diseases, tested in ongoing clinical trials with St. Jude Children’s Research Hospital, Duke Clinical Research Institute and more, ...

REDWOOD CITY, Calif., April 29, 2025--(BUSINESS WIRE)--Karius®, Inc., a leader in metagenomic sequencing for infectious disease diagnostics, announces the launch of Karius Focus | BAL, a microbial ...

A company developing liquid biopsy technology for use in diagnosing infectious diseases has netted a big investment from SoftBank and others. Redwood City, California-based Karius said Monday that it ...

Please provide your email address to receive an email when new articles are posted on . The manufacturer of the Karius Test is seeking to market it for diagnosing lung infections in immunocompromised ...

REDWOOD CITY, Calif., Feb. 11, 2019 /PRNewswire/ -- Karius, a life sciences company, announced today that the peer-reviewed journal Nature Microbiology published a study validating the Karius® Test ...

The new partnership between Capstone Health Alliance and Karius provides more patients with access to the innovative the Karius Test® technology and helps improve the diagnosis of infections REDWOOD ...

Results of a pilot study announced Wednesday showed that a next-generation sequencing test for detecting infections showed a high degree of sensitivity in children with leukemia. Redwood City, ...

Karius Inc., a global leader in liquid biopsy for infectious diseases, harnesses metagenomics, next-generation sequencing, and artificial intelligence (AI) to help enhance the precision and speed of ...